Kent Overmyer, MD
Pain Medicine · Gulfport, MSNPI 1821104365
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 88 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 21 manufacturers, the largest accounting for just 14.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $448 and has fallen 79.3% since, to $93 in 2025. That places this record below the midpoint for pain medicine clinicians in MS, where the typical reported total is $3,332.
Across 88 payments — averaging $17.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Collegium Pharmaceutical, Inc.$224
- Teva Pharmaceuticals USA, Inc.$190
- Lilly USA, LLC$146
- Boston Scientific$142
- Amgen$115
- Biodelivery Sciences International, Inc.$97
- plus $639 from 15 others
What the payments were for
- Food & beverage$1,554100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 14 | $224 |
| Teva Pharmaceuticals USA, Inc. | 7 | $190 |
| Lilly USA, LLC | 8 | $146 |
| Boston Scientific | 8 | $142 |
| Amgen(2 entities) | 7 | $115 |
| Biodelivery Sciences International, Inc. | 7 | $97 |
| Medtronic(2 entities) | 6 | $94 |
| Idorsia Pharmaceuticals US Inc | 6 | $92 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $73 |
| Biotronik NRO, Inc. | 3 | $72 |
| Abbott | 3 | $69 |
| Scilex Pharmaceuticals Inc. | 3 | $45 |
| Pfizer | 3 | $38 |
| IBSA Pharma Inc. | 2 | $34 |
| Pacira Pharmaceuticals Incorporated | 1 | $22 |
| Vertex | 1 | $20 |
| Nevro Corp. | 1 | $20 |
| Forte Bio-pharma LLC | 1 | $20 |
| Daiichi Sankyo Inc. | 1 | $16 |
| Baxter Healthcare | 1 | $13 |
| Flowonix Medical Incorporated | 1 | $12 |
How this compares
$1,554 in reported general payments places this provider in the 35th percentile of 48 pain medicine providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lidocaine | 32 | $3,020 |
| Gabapentin | 120 | $1,997 |
| Pregabalin | 89 | $1,167 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 43 | $1,055 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 20 | $786 |
| Tizanidine Hcl | 70 | $716 |
| Baclofen | 50 | $497 |
| Ibuprofen | 37 | $353 |
| Memantine Hcl | 14 | $333 |
| Celecoxib | 21 | $294 |
| Diclofenac Sodium | 12 | $245 |
| Cyclobenzaprine Hcl | 22 | $195 |
| Doxepin Hcl | 19 | $190 |
| Clonazepam | 21 | $175 |
| Naproxen | 28 | $167 |
Paid to pharmacies, not to this prescriber.
Other pain medicine in Gulfport
- Dustin DuracherGulfport$3K
- Brian DixGulfport$1K
- Rayhan TariqLaurel$64K
- Alan TorreyVicksburg$30K
- Landon BurnsFlowood$22K
- Joe CookByram$21K
- Bretley SitzmanHattiesburg$18K
- Michael ScarbroughCorinth$15K
- Casey OrzechowiczJackson$15K
- Anand PremJackson$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.